2024
“Peace of Mind” After Mastectomy: A Scoping Review
Hamid S, Bakkila B, Schultz K, Grimshaw A, Gunderson C, Godfrey E, Lee C, Berger E, Rosenberg S, Greenup R. “Peace of Mind” After Mastectomy: A Scoping Review. Annals Of Surgical Oncology 2024, 31: 5168-5179. PMID: 38717543, DOI: 10.1245/s10434-024-15360-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsContralateral prophylactic mastectomyUnilateral mastectomyBreast-conserving therapyAverage-risk womenInclusion criteriaPsychosocial well-beingProspective cohort studyBackgroundMany womenProphylactic mastectomyScoping reviewMethodsNine databasesWhite/Caucasian womenCohort studyStudy samplePostoperative time pointsStatistically significant resultsRelevant articlesWell-beingAnxietyResultsThe inclusion criteriaWomenMastectomySignificant resultsSurgical choiceSurgical decision
2018
The quality of breast cancer quality measures.
Lane W, Rushing C, Nussbaum D, Blazer D, Greenup R. The quality of breast cancer quality measures. Journal Of Clinical Oncology 2018, 36: 108-108. DOI: 10.1200/jco.2018.36.30_suppl.108.Peer-Reviewed Original ResearchBreast conserving surgeryContralateral prophylactic mastectomyImmediate breast reconstructionBreast cancer careBreast careCancer carePatient preferencesBreast cancer quality measuresMultivariable logistic regression modelFacility-level ratesHigh rateCancer quality measuresEarly-stage cancerLogistic regression modelsProbability of treatmentConserving surgeryEvidence-based practiceProphylactic mastectomyBreast reconstructionTreatment decisionsStage cancerAmerican CollegePatient valuesPredictive valuePatient choice
2016
Surgeons’ Perspectives of Contralateral Prophylactic Mastectomy
Bellavance E, Peppercorn J, Kronsberg S, Greenup R, Keune J, Lynch J, Collyar D, Magder L, Tilburt J, Hlubocky F, Yao K. Surgeons’ Perspectives of Contralateral Prophylactic Mastectomy. Annals Of Surgical Oncology 2016, 23: 2779-2787. PMID: 27169770, DOI: 10.1245/s10434-016-5253-9.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAttitude of Health PersonnelComprehensionFemaleGenes, BRCA1Genes, BRCA2HumansMaleMedical OveruseMiddle AgedPatientsPractice Patterns, Physicians'Prophylactic MastectomyRisk AssessmentRisk FactorsSurgical OncologySurveys and QuestionnairesUnilateral Breast NeoplasmsConceptsContralateral prophylactic mastectomyOncologic benefitProphylactic mastectomyBreast cancerBenefits of CPMUnfavorable risk/benefit ratioUse of CPMRisk/benefit ratioAverage-risk patientsDeleterious BRCA mutationsProportion of surgeonsInadequate patient understandingPercent of respondentsMedian ageBRCA mutationsBreast diseaseBreast surgeonsPractice patternsRelative riskPatient understandingCommon reasonMost surgeonsMethodsA surveyPatientsSurgeons
2014
Management of Positive Sub‐areolar/Nipple Duct Margins in Nipple‐Sparing Mastectomies
Camp M, Coopey S, Tang R, Colwell A, Specht M, Greenup R, Gadd M, Brachtel E, Austen W, Smith B. Management of Positive Sub‐areolar/Nipple Duct Margins in Nipple‐Sparing Mastectomies. The Breast Journal 2014, 20: 402-407. PMID: 24890641, DOI: 10.1111/tbj.12279.Peer-Reviewed Original ResearchConceptsNipple-sparing mastectomyNipple-areola complexPositive marginsNAC specimensCancer-bearing breastsResidual invasive cancerRetrospective chart reviewInvasive lobular carcinomaResidual DCISChart reviewResidual malignancyDuctal carcinomaInvasive cancerLobular carcinomaProphylactic mastectomyDuctal tissueAreola complexTreatment informationMastectomyCarcinomaTissue removalNippleFuture studiesDCISMalignancy